The tumor specimens were examined using immunohistochemistry, and results showed the level of Bcl-2 and YAP were down-regulated (Figure 8C, 8J, 8K), but the expression of PTEN and PI3K was upregulated in the FR5-treated groups (Figure 8C, 8H, 8I). The gene discussed is BCL2; the disease is neoplasm.